These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 34774715)

  • 1. Optimization study of combined enteric and time-dependent polymethacrylates as a coating for colon targeted delivery of 5-ASA pellets in rats with ulcerative colitis.
    Shahdadi Sardou H; Akhgari A; Mohammadpour AH; Beheshti Namdar A; Kamali H; Jafarian AH; Afrasiabi Garekani H; Sadeghi F
    Eur J Pharm Sci; 2022 Jan; 168():106072. PubMed ID: 34774715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of 5-ASA layered or matrix pellets coated with a combination of ethylcellulose and eudragits L and s in the treatment of ulcerative colitis in rats.
    Sardou HS; Sadeghi F; Garekani HA; Akhgari A; Hossein Jafarian A; Abbaspour M; Nokhodchi A
    Int J Pharm; 2023 Jun; 640():122981. PubMed ID: 37120124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of inulin/Eudragit RS in 5-ASA pellet coating with tuned, sustained-release feature in an animal model of ulcerative colitis.
    Shahdadi Sardou H; Akhgari A; Mohammadpour AH; Kamali H; Jafarian AH; Afrasiabi Garekani H; Sadeghi F
    Int J Pharm; 2021 Mar; 597():120347. PubMed ID: 33545282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation and evaluation of colon adhesive pellets of 5-aminosalicylic acid.
    Xu M; Sun M; Qiao H; Ping Q; Elamin ES
    Int J Pharm; 2014 Jul; 468(1-2):165-71. PubMed ID: 24746693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statistical optimization of indomethacin pellets coated with pH-dependent methacrylic polymers for possible colonic drug delivery.
    Akhgari A; Afrasiabi Garekani H; Sadeghi F; Azimaie M
    Int J Pharm; 2005 Nov; 305(1-2):22-30. PubMed ID: 16236475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time- and pH-dependent colon-specific drug delivery for orally administered diclofenac sodium and 5-aminosalicylic acid.
    Cheng G; An F; Zou MJ; Sun J; Hao XH; He YX
    World J Gastroenterol; 2004 Jun; 10(12):1769-74. PubMed ID: 15188503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination of time-dependent and pH-dependent polymethacrylates as a single coating formulation for colonic delivery of indomethacin pellets.
    Akhgari A; Sadeghi F; Garekani HA
    Int J Pharm; 2006 Aug; 320(1-2):137-42. PubMed ID: 16782290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feasibility studies of concomitant administration of optimized formulation of probiotic-loaded Vancomycin hydrochloride pellets for colon delivery.
    Avachat AM; Shinde AS
    Drug Dev Ind Pharm; 2016 Jan; 42(1):80-90. PubMed ID: 25923416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and characterization of colon specific drug delivery system bearing 5-ASA and Camylofine dihydrochloride for the treatment of ulcerative colitis.
    Dubey R; Dubey R; Omrey P; Vyas SP; Jain SK
    J Drug Target; 2010 Sep; 18(8):589-601. PubMed ID: 20088681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel pH- and time-based multi-unit potential colonic drug delivery system. I. Development.
    Gupta VK; Beckert TE; Price JC
    Int J Pharm; 2001 Feb; 213(1-2):83-91. PubMed ID: 11165096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioadhesive pellets increase local 5-aminosalicylic acid concentration in experimental colitis.
    Bautzová T; Rabišková M; Béduneau A; Pellequer Y; Lamprecht A
    Eur J Pharm Biopharm; 2012 Jun; 81(2):379-85. PubMed ID: 22386911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chitosan/Kollicoat SR 30D film-coated pellets of aminosalicylates for colonic drug delivery.
    Wei H; Li-Fang F; Min B; Yong-Zhen C; Bai X; Qing D; Feng W; Min Q; De-Ying C
    J Pharm Sci; 2010 Jan; 99(1):186-95. PubMed ID: 19655374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formulation and optimization of a single-layer coat for targeting budesonide pellets to the descending Colon.
    Soltani F; Kamali H; Akhgari A; Afrasiabi Garekani H; Nokhodchi A; Sadeghi F
    Pharm Dev Technol; 2024 Mar; 29(3):212-220. PubMed ID: 38392961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new 5-aminosalicylic acid multi-unit dosage form for the therapy of ulcerative colitis.
    Rudolph MW; Klein S; Beckert TE; Petereit H; Dressman JB
    Eur J Pharm Biopharm; 2001 May; 51(3):183-90. PubMed ID: 11343881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo efficacy of microbiota-sensitive coatings for colon targeting: a promising tool for IBD therapy.
    Karrout Y; Dubuquoy L; Piveteau C; Siepmann F; Moussa E; Wils D; Beghyn T; Neut C; Flament MP; Guerin-Deremaux L; Dubreuil L; Deprez B; Desreumaux P; Siepmann J
    J Control Release; 2015 Jan; 197():121-30. PubMed ID: 25445696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of polymer coating on faecal recovery of ingested 5-amino salicylic acid in patients with ulcerative colitis.
    Mardini HA; Lindsay DC; Deighton CM; Record CO
    Gut; 1987 Sep; 28(9):1084-9. PubMed ID: 3678967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enteric-coated gelatin nanoparticles mediated oral delivery of 5-aminosalicylic acid alleviates severity of DSS-induced ulcerative colitis.
    Ahmad A; Ansari MM; Mishra RK; Kumar A; Vyawahare A; Verma RK; Raza SS; Khan R
    Mater Sci Eng C Mater Biol Appl; 2021 Feb; 119():111582. PubMed ID: 33321628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple response optimisation of processing and formulation parameters of pH sensitive sustained release pellets of capecitabine for targeting colon.
    Pandey S; Swamy SMV; Gupta A; Koli A; Patel S; Maulvi F; Vyas B
    J Microencapsul; 2018 May; 35(3):259-271. PubMed ID: 29659317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and in vitro evaluation of mesalamine delayed release pellets and tableted reservoir-type pellets.
    Bendas ER; Christensen JM; Ayres JW
    Drug Dev Ind Pharm; 2010 Apr; 36(4):393-404. PubMed ID: 19740039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of Pharmaceutical Formulation on the Mucosal Concentration of 5-Aminosalicylic Acid and N-Acetylmesalamine in Japanese Patients with Ulcerative Colitis.
    Yamamoto Y; Masuda S; Nakase H; Matsuura M; Maruyama S; Hisamatsu T; Suzuki Y; Matsubara K
    Biol Pharm Bull; 2019 Jan; 42(1):81-86. PubMed ID: 30369547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.